Baker Ellis Asset Management LLC Makes New Investment in The Clorox Company (NYSE:CLX)

Baker Ellis Asset Management LLC acquired a new stake in The Clorox Company (NYSE:CLX) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 1,400 shares of the company’s stock, valued at approximately $214,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Choreo LLC raised its holdings in shares of Clorox by 12.8% in the fourth quarter. Choreo LLC now owns 5,741 shares of the company’s stock valued at $819,000 after purchasing an additional 652 shares during the last quarter. abrdn plc raised its holdings in shares of Clorox by 20.1% in the fourth quarter. abrdn plc now owns 198,250 shares of the company’s stock valued at $28,268,000 after purchasing an additional 33,135 shares during the last quarter. Savoir Faire Capital Management L.P. raised its holdings in shares of Clorox by 61.8% in the fourth quarter. Savoir Faire Capital Management L.P. now owns 65,192 shares of the company’s stock valued at $9,296,000 after purchasing an additional 24,897 shares during the last quarter. Banque Cantonale Vaudoise raised its holdings in shares of Clorox by 78.2% in the first quarter. Banque Cantonale Vaudoise now owns 29,335 shares of the company’s stock valued at $4,492,000 after purchasing an additional 12,872 shares during the last quarter. Finally, Game Plan Financial Advisors LLC acquired a new stake in shares of Clorox in the first quarter valued at approximately $1,025,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on CLX shares. Morgan Stanley reiterated an “equal weight” rating and issued a $160.00 price objective on shares of Clorox in a report on Tuesday, March 26th. DA Davidson restated a “neutral” rating and set a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th. Evercore ISI lowered their target price on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a report on Wednesday, May 1st. Citigroup lowered their target price on shares of Clorox from $155.00 to $150.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Finally, Wells Fargo & Company lowered their target price on shares of Clorox from $140.00 to $135.00 and set an “underweight” rating on the stock in a report on Thursday, May 2nd. Five equities research analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the stock. Based on data from MarketBeat.com, Clorox currently has an average rating of “Hold” and an average price target of $145.33.

Clorox Trading Down 0.1 %

Shares of Clorox stock opened at $136.47 on Friday. The firm has a 50-day moving average of $136.95 and a 200-day moving average of $143.80. The stock has a market cap of $16.95 billion, a PE ratio of 70.71, a PEG ratio of 2.19 and a beta of 0.39. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.14. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90.

Clorox (NYSE:CLX) last announced its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. The company had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. Clorox’s quarterly revenue was down 5.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.51 earnings per share. As a group, sell-side analysts forecast that The Clorox Company will post 5.91 EPS for the current year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.